Evidence map›Paper›PMID 26155792›Full record

ArticleBMC complementary and alternative medicine2015

Antitumor and antimetastatic activities of chloroform extract of medicinal mushroom Cordyceps taii in mouse models.

Ru-Ming Liu, Xiao-Jie Zhang, Gui-You Liang, Yong-Fu Yang, Jian-Jiang Zhong, Jian-Hui Xiao

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. The GenusLife (Basel, Switzerland) · 2025
    Review
  2. Review
  3. Molecules (Basel, Switzerland) · 2024
    Review
  4. Review
  5. Frontiers in pharmacology · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ru-Ming LiuGuizhou Center for Translational Medicine & Laboratory of Cell Engineering, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, China. lrm407@126.com.
Xiao-Jie ZhangGuizhou Center for Translational Medicine & Laboratory of Cell Engineering, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, China. mycoxiao@aliyun.com.
Gui-You LiangGuizhou Center for Translational Medicine & Laboratory of Cell Engineering, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, China. guiyou515@163.com.
Yong-Fu YangDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, China. yyf8624236@sina.com.
Jian-Jiang ZhongState Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic & Developmental Sciences, and School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China. jjzhong@sjtu.edu.cn.
Jian-Hui XiaoGuizhou Center for Translational Medicine & Laboratory of Cell Engineering, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, China. jhxiao@yahoo.com.
Zunyi Medical University · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCordyceps taii, an entomogenous fungus native to south China, is a folk medicine with varieties of pharmacological activities including anticancer effect. To validate the ethnopharmacological claim against cancer, the antitumor and antimetastatic activities of chloroform extract of C. taii (CFCT) were investigated in vivo.

methodsThe in vitro cytotoxic activities of CFCT against human lung cancer (A549) and gastric cancer (SGC-7901) cells were evaluated using the Sulforhodamine B (SRB) assay. In vivo anti tumor and antimetastatic activities, Kunming mice bearing sarcoma 180 and C57BL/6 mice bearing melanoma B16F10 were employed, respectively. The antitumor effects of CFCT were completely evaluated on the basis of the tumor weight, survival time, histologic analysis, and immune organ indices. The histopathological change, metastatic foci and malignant melanoma specific marker HMB45 in the lung tissue were detected for the evaluation of the antimetastatic activity of CFCT.

resultsCFCT exhibited dose- and time-dependent cytotoxicities against A549 and SGC-7901 cells with the IC50 values of 30.2 and 65.7 μg/mL, respectively. Furthermore, CFCT at a dose of 50 or 100 mg/kg could significantly inhibit the tumor growth in vivo and prolonged the survival time in two different models as compared with the model group, especially when combined with the CTX at a low dose rate. And it also increased spleen index of Kunming mice and thymus index of C57BL/6 mice. Meanwhile, histologic analysis illustrated that CFCT alone or in combination with CTX could induce tumor tissue necrosis of both models. In addition, CFCT at a dose of 50 or 100 mg/kg inhibited the lung metastasis of melanoma B16F10 in tumor-bearing C57BL/6 mice. The antimetastatic effect was also observed when CFCT was used in combination with CTX. In comparison to any other groups, CFCT at a dose of 100 mg/kg could effectively enhance the GSH-Px activities of various tissues in tumor-bearing C57BL/6 mice.

conclusionsThese findings demonstrate that CFCT has potent in vivo antitumor and antimetastatic activities, and may be helpful to the development of anticancer chemopreventive agents from C. taii.

Indexed as

AnimalsAntineoplastic AgentsBiological ProductsCell Line, TumorCordycepsHumansLungLung NeoplasmsMiceMice, Inbred C57BLXenograft Model Antitumor AssaysAntineoplastic AgentsBiological Products

Identifiers

PMID26155792
PMCPMC4495694
OpenAlexW2099593789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.